本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Bone Biologics Corp

0.5400
-0.0001-0.02%
盤後0.56300.0230+4.26%19:25 EDT
成交量:10.38萬
成交額:5.57萬
市值:148.83萬
市盈率:-0.34
高:0.5798
開:0.5320
低:0.5101
收:0.5401
52周最高:2.89
52周最低:0.5101
股本:275.61萬
流通股本:275.54萬
量比:3.99
換手率:3.77%
股息:- -
股息率:- -
每股收益(TTM):-1.6080
每股收益(LYR):-2.6500
淨資產收益率:-54.96%
總資產收益率:-33.46%
市淨率:0.38
市盈率(LYR):-0.20

資料載入中...

2022/05/23

重要事件披露

8-K - Current report
2022/05/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/03/15

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/08

重要事件披露

8-K - Current report
2021/12/22

重要事件披露

8-K - Current report
2021/10/21

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/10/21

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/10/19

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/08

SEC問詢函

CORRESP [Cover] - Correspondence
2021/10/08

SEC問詢函

CORRESP [Cover] - Correspondence
2021/10/07

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/10/06

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/08/30

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/08/16

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/06/28

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2021/06/07

重要事件披露

8-K - Current report
2021/05/21

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/15

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/15

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/15

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]